Sernova Biotherapeutics Inc
Open
$0.17
Prev. Close
$0.17
High
$0.17
Low
$0.17
Market Snapshot
$67.34M
-0.04
8
Sernova Biotherapeutics Inc. is a clinical-stage biotechnology company, which engages in advancing regenerative medicine in the treatment of chronic diseases. The company is headquartered in London, Ontario and currently employs 17 full-time employees. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on type 1 diabetes (T1D) and thyroid disorders. Cell Pouch is a bio-hybrid organ which is surgically implanted beneath the skin of the abdomen.
emptyResult
Sernova Biotherapeutics Inc. is a clinical-stage biotechnology company, which engages in advancing regenerative medicine in the treatment of chronic diseases. The company is headquartered in London, Ontario and currently employs 17 full-time employees. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on type 1 diabetes (T1D) and thyroid disorders. Cell Pouch is a bio-hybrid organ which is surgically implanted beneath the skin of the abdomen.
Recently from Cashu
Couldn't load Cashu news
Something went wrong. Try refreshing the page.